Midas Letter RAW 67: Canntab Therapeutics, International Cannabrands & Justin B. Marshall

1,769 views · Published 25 September 2018 · 1:30:24 · Indexed 31 October 2026

Channel: Midas Letter · 2018 · News & Politics

Watch on YouTube

Midas Letter RAW highlights the stocks and stories to watch in the Canadian markets today. James West and Ed Milewski provides comprehensive fundamental & technical analysis on all trending business and investment news, while interviewing the top CEOs of all public companies and analysts with the highest reputations in the business.

15:26 – Canntab Therapeutics Ltd (CNSX:PILL) (OTCMKTS:TLFTF) (FRA:TBF1) CEO Jeff Renwick and CFO Richard Goldstein discuss the doubling of the company’s stock. Canntab produces a hard tablet for cannabis oral delivery in the medicinal cannabis space and the pair are hopeful Health Canada will approve this delivery method.

28:31 – International Cannabrands Inc (CNSX:JUJU) (OTCMKTS:GEATF) (FRA:31G) CEO Steve Gormley talks about the company’s recent deals, including a distribution agreement within the Washington State market.

59:42 – West Coast correspondent Justin B. Marshall talks with lawyer Aaron Johnson, a cannabis attorney, about greenhouse builds in Monterey.

************************

Check out our website: 
https://MidasLetter.com

************************

SUBSCRIBE to our YouTube: 
http://bit.ly/MidasLetterYoutube 

SUBSCRIBE to our Newsletter:
http://bit.ly/MidasLetterNewsletter 

Download Our Podcast on iTunes:
http://bit.ly/MidasLetterPodcast

************************

Follow Us on Twitter: 
http://bit.ly/MidasLetterTwitter

Like Us on Instagram: 
http://bit.ly/MidasLetterInsta 

Like Us on Facebook: 
http://bit.ly/MidasLetterFacebook

************************

#MidasLetter
#TechnicalAnalysis
#WeedStocks

More from this channel